Huang Y - Search Results

1

A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.

Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, Tang X, Zhu J, Zhao Z, Jaffré F, Zhang T, Kim TW, Harschnitz O, Redmond D, Houghton S, Liu C, Naji A, Ciceri G, Guttikonda S, Bram Y, Nguyen DT, Cioffi M, Chandar V, Hoagland DA, Huang Y, Xiang J, Wang H, Lyden D, Borczuk A, Chen HJ, Studer L, Pan FC, Ho DD, tenOever BR, Evans T, Schwartz RE, Chen S. Yang L, et al. Among authors: huang y. Cell Stem Cell. 2020 Jul 2;27(1):125-136.e7. doi: 10.1016/j.stem.2020.06.015. Epub 2020 Jun 19. Cell Stem Cell. 2020. PMID: 32579880 Free PMC article.

2

Identification and quantitation of HIV-1 in the liver of patients with AIDS.

Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, Ho DD. Cao YZ, et al. Among authors: huang yx. AIDS. 1992 Jan;6(1):65-70. doi: 10.1097/00002030-199201000-00008. AIDS. 1992. PMID: 1543567

3

Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.

Moore JP, McKeating JA, Huang YX, Ashkenazi A, Ho DD. Moore JP, et al. Among authors: huang yx. J Virol. 1992 Jan;66(1):235-43. doi: 10.1128/JVI.66.1.235-243.1992. J Virol. 1992. PMID: 1727487 Free PMC article.

4

CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro.

Cao YZ, Friedman-Kien AE, Huang YX, Li XL, Mirabile M, Moudgil T, Zucker-Franklin D, Ho DD. Cao YZ, et al. Among authors: huang yx. J Virol. 1990 Jun;64(6):2553-9. doi: 10.1128/JVI.64.6.2553-2559.1990. J Virol. 1990. PMID: 2159530 Free PMC article.

5

CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV).

Chen Z, Zhao X, Huang Y, Gettie A, Ba L, Blanchard J, Ho DD. Chen Z, et al. Among authors: huang y. J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):133-45. doi: 10.1097/00042560-200206010-00001. J Acquir Immune Defic Syndr. 2002. PMID: 12045675

6

The HIV-1 vaccine race.

Ho DD, Huang Y. Ho DD, et al. Among authors: huang y. Cell. 2002 Jul 26;110(2):135-8. doi: 10.1016/s0092-8674(02)00832-2. Cell. 2002. PMID: 12150921 Free article. Review.

7

Multiple-site DNA vaccination enhances immune responses in mice.

Gardiner DF, Huang Y, Basu S, Leung L, Song Y, Chen Z, Ho DD. Gardiner DF, et al. Among authors: huang y. Vaccine. 2006 Jan 16;24(3):287-92. doi: 10.1016/j.vaccine.2005.07.075. Epub 2005 Aug 8. Vaccine. 2006. PMID: 16137804

8

Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.

Simon V, Zennou V, Murray D, Huang Y, Ho DD, Bieniasz PD. Simon V, et al. Among authors: huang y. PLoS Pathog. 2005 Sep;1(1):e6. doi: 10.1371/journal.ppat.0010006. Epub 2005 Jul 22. PLoS Pathog. 2005. PMID: 16201018 Free PMC article.

9

Design, construction, and characterization of a multigenic modified vaccinia Ankara candidate vaccine against human immunodeficiency virus type 1 subtype C/B'.

Chen Z, Huang Y, Zhao X, Ba L, Zhang W, Ho DD. Chen Z, et al. Among authors: huang y. J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):412-21. doi: 10.1097/QAI.0b013e3181651bb2. J Acquir Immune Defic Syndr. 2008. PMID: 18209682

10

Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant.

Huang Y, Chen Z, Zhang W, Gurner D, Song Y, Gardiner DF, Ho DD. Huang Y, et al. J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):403-11. doi: 10.1097/QAI.0b013e3181651b9d. J Acquir Immune Defic Syndr. 2008. PMID: 18209683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75,329 results

Search Page